Thermo Fischer Scientific Inc, Illumina, Inc. and Abbott are Dominating the Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market in 2020

Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market is expected to grow with the CAGR of 10.4% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-kirsten-rat-sarcoma-kras-market

Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario. The major players dealing in Kirsten Rat Sarcoma (KRAS) market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

  • In October 2018, Ilumina Inc had launched the True Sight Oncology 500. The liquid biopsy panel, is a comprehensive pan-cancer assay, which has been designed to identify and detect known and upcoming tumor biomarkers. The panel launched by the company were used for molecular testing of biomarkers in lung cancer, being implemented for precision oncology and strengthened the Oncology portfolio. It demonstrated a positive growth in the market.

Thermo Fisher Scientific Inc., is dominating player in Kirsten Rat Sarcoma (KRAS) market. The other key players existing in the market includes Abbott, Agilent Technologies, Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Merck KGaA, EntroGen, Inc., ViennaLab Diagnostics GmbH, Sysmex Inostics, DiaCarta, Takara Bio Inc., Illumina, Inc., Amoy Diagnostics Co., Ltd., Agena Bioscience, Inc., Proteintech Group, Inc., Biocartis among others.

Asia-Pacific Kirsten Rat Sarcoma (KRAS) MarketTHERMO FISCHER SCIENTIFIC INC

Thermo Fisher Scientific Inc., headquartered in Massachusetts, U.S. was founded in 2006. The company engages in the development, manufacture, marketing and sale of medical devices. The company offers Laboratory Supplies, Laboratory Equipment, Laboratory Instruments, Clinical & Diagnostics, Chromatography & Mass Spectrometry, Cell Culture, Protein and Cell Analysis, Molecular Biology & Nucleic Acid Analysis, Sequence-Specific Nucleic Acid Products. The company has presence in North America, Europe, and Asia-Pacific. The company has various subsidiaries that are Smith & Nephew Argentina S.R.L.2 (Argentina), Smith & Nephew Pty Limited (Australia), Smith & Nephew Medical (Shanghai) Limited (China), Smith & Nephew S.A. de C.V. (Mexico), Smith & Nephew Limited1 (New Zealand) among others.

For instance,

  • In October 2020, Thermo Fischer Scientific Inc, had announced to extend its collaboration with Symphogen, to provide nnovative cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry workflows. The companies can provide the biopharmaceutical industry with compliance ready mass spectrometer solutions to boost the drug delivery. It would deliver a positive growth in the market. 

Illumina, Inc

Illumina, Inc  is headquartered in San Diego, U.S.  and was founded in 1998. The company is a leading developer, manufacturer and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company offers Clinical Research Products, Sequencing Reagents and Flow Cells, In Vitro Diagnostic (IVD) Products, Molecular Biology Reagents, Library Preparation Kits, Software and Informatics, Microarray Kits. The company has presence in Americas, Europe, Asia-Pacific, Middle East and Africa. The company has various subsidiaries that are Bluebee Holding B.V. (Netherlands), Genologics (Canada), GRAIL (California), Advanced Liquid Logic (U.S.) among others.     

For instance,

  • In January 2021, Illumina Inc had announced the Oncology partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck for Advanced Comprehensive Genomic Profiling. The partnerships would result in the company’s aim to develop standardized tools for precision oncology. It would deliver positive growth in the market.

Abbott

Abbott is headquartered in Illinois, U.S.  And was founded in 1888. The company is focused on providing the good health to the people around the world through their innovative medicines and technologies. The company offers Consumers and Health Professionals. The company has a presence in Asia-Pacific, Europe, Middle East and Africa, Americas. The company has various subsidiaries that are Alere Inc. (U.S.), Panbio Ltd (Australia), Abbott India Ltd (Mumbai), Abbott Japan Co., Ltd. (Japan), Abbott Canada (Canada) among others.  

For instance,

  • In January 2021, Abbott announced that they had received a corporate excellence award for it’s a collaboration to expand access to sustainable, quality care in rural Rwanda, working together with the Rwandan Ministry of Health (MoH) and the non-profit organization Society for Family Health Rwanda (SFH Rwanda). This will expands the business to these emerging and low-income countries.